Prostaglandin D2 strengthens human endothelial barrier by activation of E-type receptor 4

[Display omitted] Life-threatening inflammatory conditions such as acute respiratory distress syndrome or sepsis often go hand in hand with severe vascular leakage. During inflammation, endothelial cell integrity and intact barrier function are crucial to limit leukocyte and plasma extravasation. Pr...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical pharmacology 2020-12, Vol.182, p.114277-114277, Article 114277
Main Authors: Rittchen, Sonja, Rohrer, Kathrin, Platzer, Wolfgang, Knuplez, Eva, Bärnthaler, Thomas, Marsh, Leigh M., Atallah, Reham, Sinn, Katharina, Klepetko, Walter, Sharma, Neha, Nagaraj, Chandran, Heinemann, Akos
Format: Article
Language:English
Subjects:
Barrier disruption
BW245c
Endothelial barrier
EP4 receptor
Microvascular endothelium
Prostaglandin D2
Prostanoid signalling
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] Life-threatening inflammatory conditions such as acute respiratory distress syndrome or sepsis often go hand in hand with severe vascular leakage. During inflammation, endothelial cell integrity and intact barrier function are crucial to limit leukocyte and plasma extravasation. Prostaglandin D2 (PGD2) is a potent inflammatory lipid mediator with vasoactive properties. Previous studies suggest that PGD2 is involved in the regulation of endothelial barrier function; however, it is unclear whether this is also true for primary human pulmonary microvascular endothelial cells. Furthermore, as PGD2 is a highly promiscuous ligand, we set out to determine which receptors are important in human pulmonary endothelial cells. In the current study, we found that PGD2 and the DP1 agonist BW245c potently strengthened pulmonary and dermal microvascular endothelial cell barrier function and protected against thrombin-induced barrier disruption. Yet surprisingly, these effects were mediated only to a negligible extent via DP1 receptor activation. In contrast, we observed that the EP4 receptor was most important and mediated the barrier enhancement by PGD2 and BW245c. Stimulation with PGE2 or PGD2 reduced AKT phosphorylation which could be reversed by prior blockade of EP4 receptors. These data demonstrate a novel mechanism by which PGD2 may modulate inflammation and emphasizes the role of EP4 receptors in human endothelial cell function.
ISSN:0006-2952
1873-2968
DOI:10.1016/j.bcp.2020.114277